Jon Vialoux
Procter & Gamble
PG-N
WATCH
May 18, 2018
From June to October is the right period to buy this. Defensive name. Longer term momentum is not on its side. It is trading a down channel. MSCD is positive diverting. Selling pressure is waning. If you see it go over 75 might be an opportunity to buy.
Very stable, reliable earnings. Decent, but not fantastic, growth. About 7% earnings growth forecast for next little while, but you're paying 23-24x PE.
OK if you think a recession is around the corner. He doesn't, so he'd favour COST and WMT for continued mid-cycle economic growth.
Trades at 24x forward PE at only 1% organic growth. She's surprised they raised prices again, though they have pricing power, but at some point it will hurt volumes.
They beat on the topline, but missed the bottom, because China was -15%, though it was expected. Organic sales were fine and reiterated guidance. Trades at a too-pricey 24x forward. He doesn't like staples, but continues to like this.
A dividend play for 2025 at 2.38%. Not sexy, but consistently generates earnings, free cash flow, and each year grows its dividend. Offers growth wealth generation over time.
Is enjoying the rotation out of semis/tech stocks today, up 3.38%. It's been undervalued lately. Has more room to run; he expects the rotation to continue beyond today.
It has one of the greatest consumer product lines in the world. A dividend aristocrat that has raised its dividend for 70 years. It yields only a 2.68% dividend yield, falling short of current interest rates and bond yields.
From June to October is the right period to buy this. Defensive name. Longer term momentum is not on its side. It is trading a down channel. MSCD is positive diverting. Selling pressure is waning. If you see it go over 75 might be an opportunity to buy.